Paper33488583
Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
Lee SK and 12 others. Front Immunol, 2020. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance. Papers, record 33488583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33488583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Homeostasis | Major topic |
| Metformin | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Tacrolimus | Major topic |
| Th17 Cells | Major topic |
| Adolescent | |
| Animals | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Cell Proliferation | |
| Cells, Cultured | |
| Drug Therapy, Combination | |
| Female | |
| Graft vs Host Disease | |
| Humans | |
| Leukocytes, Mononuclear | |
| Lymphocyte Activation | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31884044 | Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. | Biochem Pharmacol | 2020 | https://conductscience.org/library/papers/31884044 | PubMed |
| 2 | 29175009 | Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity. | Clin Res Hepatol Gastroenterol | 2018 | https://conductscience.org/library/papers/29175009 | PubMed |
| 3 | 26615097 | Treg Cell Differentiation: From Thymus to Peripheral Tissue. | Prog Mol Biol Transl Sci | 2015 | https://conductscience.org/library/papers/26615097 | PubMed |
| 4 | 27126953 | Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs. | Transl Res | 2016 | https://conductscience.org/library/papers/27126953 | PubMed |
| 5 | 29545795 | Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation. | Front Immunol | 2018 | https://conductscience.org/library/papers/29545795 | PubMed |
| 6 | 28584086 | IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28584086 | PubMed |
| 7 | 31965710 | Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction. | Am J Transplant | 2020 | https://conductscience.org/library/papers/31965710 | PubMed |
| 8 | 22994804 | Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. | Am J Transplant | 2012 | https://conductscience.org/library/papers/22994804 | PubMed |
| 9 | 30118680 | Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. | Mol Cell | 2018 | https://conductscience.org/library/papers/30118680 | PubMed |
| 10 | 25624476 | Immune-mediated antitumor effect by type 2 diabetes drug, metformin. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25624476 | PubMed |
| 11 | 30633591 | Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients. | Immunopharmacol Immunotoxicol | 2019 | https://conductscience.org/library/papers/30633591 | PubMed |
| 12 | 17446564 | Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. | Stem Cells | 2007 | https://conductscience.org/library/papers/17446564 | PubMed |
| 13 | 31319067 | Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31319067 | PubMed |
| 14 | 25214721 | Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis. | Mediators Inflamm | 2014 | https://conductscience.org/library/papers/25214721 | PubMed |
| 15 | 29915588 | Metformin and Autoimmunity: A "New Deal" of an Old Drug. | Front Immunol | 2018 | https://conductscience.org/library/papers/29915588 | PubMed |
| 16 | 17438575 | Graft-versus-host disease. | Nat Rev Immunol | 2007 | https://conductscience.org/library/papers/17438575 | PubMed |
| 17 | 9723432 | Tacrolimus is superior to cyclosporine in liver transplantation. | Transplant Proc | 1998 | https://conductscience.org/library/papers/9723432 | PubMed |
| 18 | 23205589 | The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression. | Immunology | 2013 | https://conductscience.org/library/papers/23205589 | PubMed |
| 19 | 7523946 | A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. | N Engl J Med | 1994 | https://conductscience.org/library/papers/7523946 | PubMed |
| 20 | 8569826 | Metformin. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8569826 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42256058 | Enhanced ocular delivery of tacrolimus via cationic nanoliposomes: Mitigating inflammation and rebalancing Th17/Treg responses in dry eye disease. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42256058 | PubMed |
| 41953033 | Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: a population-based cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/41953033 | PubMed |
| 41898542 | Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898542 | PubMed |
| 41695459 | De novo Inflammatory Bowel Disease following Liver and Heart Transplantation: A Case Series Exploring the Role of IL-23 Pathway-Targeted Therapy. | Inflamm Intest Dis | 2026 | https://conductscience.org/library/papers/41695459 | PubMed |
| 40134277 | Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy. | Essays Biochem | 2025 | https://conductscience.org/library/papers/40134277 | PubMed |
| 39754054 | Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions. | Mol Med | 2025 | https://conductscience.org/library/papers/39754054 | PubMed |
| 39215078 | Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab. | Sci Rep | 2024 | https://conductscience.org/library/papers/39215078 | PubMed |
| 39062560 | Metformin Restrains the Proliferation of CD4+ T Lymphocytes by Inducing Cell Cycle Arrest in Normo- and Hyperglycemic Conditions. | Biomolecules | 2024 | https://conductscience.org/library/papers/39062560 | PubMed |
| 38764823 | Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/38764823 | PubMed |
| 37886013 | Old drug, new tricks: the utility of metformin in infection and vaccination responses to influenza and SARS-CoV-2 in older adults. | Front Aging | 2023 | https://conductscience.org/library/papers/37886013 | PubMed |
| 37688662 | Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/37688662 | PubMed |
| 36902432 | An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902432 | PubMed |
| 36879838 | The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells. | Rheumatol Immunol Res | 2022 | https://conductscience.org/library/papers/36879838 | PubMed |
| 36091841 | The molecular pathogenesis of triptolide-induced hepatotoxicity. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36091841 | PubMed |
| 35662580 | Protection by metformin against severe Covid-19: An in-depth mechanistic analysis. | Diabetes Metab | 2022 | https://conductscience.org/library/papers/35662580 | PubMed |
| 35437510 | The Association between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation. | J Immunol Res | 2022 | https://conductscience.org/library/papers/35437510 | PubMed |
| 35418987 | Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/35418987 | PubMed |
| 34822394 | Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD). | Metabolites | 2021 | https://conductscience.org/library/papers/34822394 | PubMed |
| 34360634 | Potential Therapeutic Approaches through Modulating the Autophagy Process for Skin Barrier Dysfunction. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360634 | PubMed |
| 34220860 | Regulatory T Cells in GVHD Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34220860 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33488583
GET https://conductscience.org/api/papers/v1/33488583/cited_by?page=2